UK: Translational and clinical Neurooncology. Special interests: Immunotherapy, target treatment, endotoxin treatment, EGF/TGF beta interaction, Angiogenesis, more intelligent treatment with radiotherapy and systematic treatment. More intelligent use of PET/MR features.
Workgroups